Find clinical trials for Diabetes in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus

Diabetes Mellitus

Obesity

Type 1 Diabetes Mellitus

Diabetic Foot

Overweight

Foot Ulcer

Diabetes trials near Rochester, MN, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling

Diabetes

Type2diabetes

Device: ReCET Treatment

Device: Sham Procedure

Endogenex

Rochester, Minnesota, United States and 44 other locations

Status recently updated

Innovative Automated Insulin Delivery System for Type 2 Diabetes (twiist-T2D)

The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes....

Enrolling

Active, not recruiting

Insulin Treated Type 2 Diabetes Mellitus

Type 2 Diabetes

Device: twiist insulin delivery system

Deka Research and Development

Rochester, Minnesota, United States and 30 other locations

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes (βETA PRESERVE)

with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes...

Enrolling

Type 1 Diabetes Mellitus

Other: Placebo

Drug: Teplizumab

Phase 3

Sanofi

Rochester, Minnesota, United States and 28 other locations

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes (ONWARDS 11)

The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...

Enrolling

Diabetes Mellitus, Type 1

Drug: Insulin glargine

Drug: Insulin icodec

Phase 3

Novo Nordisk

Rochester, Minnesota, United States and 174 other locations

Fenofibrate for Prevention of DR Worsening (Protocol AF)

fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...

Enrolling

Diabetic Retinopathy

Other: Placebo

Drug: Fenofibrate

Phase 3

Jaeb Center for Health Research

Rochester, Minnesota, United States and 65 other locations

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR (AP)

This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combi...

Enrolling

Proliferative Diabetic Retinopathy (PDR)

Drug: Faricimab

Device: Endolaser

Phase 3

Jaeb Center for Health Research

Rochester, Minnesota, United States and 13 other locations

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully...

Active, not recruiting

Cushing Syndrome

Drug: relacorilant

Phase 2

Corcept Therapeutics

Rochester, Minnesota, United States and 47 other locations

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation (COURAGE)

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Active, not recruiting

Obesity

Drug: Matching Placebo-Trevogrumab

Drug: Matching Placebo-Garetosmab

Phase 2

Regeneron Pharmaceuticals

Rochester, Minnesota, United States and 66 other locations

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling

NASH - Nonalcoholic Steatohepatitis

Drug: Placebo

Drug: IVA337

Phase 3

Inventiva Pharma

Rochester, Minnesota, United States and 491 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Rochester, MN

Related conditions:

Diabetes trials near Rochester, MN, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

Innovative Automated Insulin Delivery System for Type 2 Diabetes (twiist-T2D)

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes (βETA PRESERVE)

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes (ONWARDS 11)

Fenofibrate for Prevention of DR Worsening (Protocol AF)

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR (AP)

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation (COURAGE)

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Find clinical trials for Diabetes in Rochester, MN